Anticancer Research: 31 (1)

January 2011; Volume 31,Issue 1

Experimental Studies

You have access
Inhibition of Tumor Cellular Proteasome Activity by Triptolide Extracted from the Chinese Medicinal Plant ‘Thunder God Vine’
LI LU, JYOTI KANWAR, SARA SCHMITT, QIUZHI CINDY CUI, CHUANYIN ZHANG, CONG ZHAO and Q. PING DOU

Anticancer Research January 2011, 31 (1) 1-10;
You have access
Frequent Absence of Tumor Suppressor FUS1 Protein Expression in Human Bone and Soft Tissue Sarcomas
GUIDONG LI, HIROYUKI KAWASHIMA, LIN JI, AKIRA OGOSE, TAKASHI ARIIZUMI, HAJIME UMEZU, YONGJUN XU, TETSUO HOTTA and NAOTO ENDO

Anticancer Research January 2011, 31 (1) 11-21;
You have access
Measuring IGF-1, ER-α and EGFR Expression Can Predict Tamoxifen-resistance in ER-positive Breast Cancer
KELVIN CHONG, ASHOK SUBRAMANIAN, ANUP SHARMA and KEFAH MOKBEL

Anticancer Research January 2011, 31 (1) 23-32;
You have access
Human Lymphoma Cells Develop Resistance to Radiation in the Presence of Astrocytes In Vitro
MASASHI KOTO, HEUNGLAE CHO, OLIVER RIESTERER, UMA GIRI, MICHAEL D. STORY, CHUL S. HA and UMA RAJU

Anticancer Research January 2011, 31 (1) 33-38;
You have access
Apoptosis of SAS Cells Induced by Sonodynamic Therapy Using 5-Aminolevulinic Acid Sonosensitizer
WEI SONG, HAIDONG CUI, RUI ZHANG, JINHUA ZHENG and WENWU CAO

Anticancer Research January 2011, 31 (1) 39-45;
You have access
Procathepsin D and Cytokines Influence the Proliferation of Lung Cancer Cells
VACLAV VETVICKA and JANA VETVICKOVA

Anticancer Research January 2011, 31 (1) 47-51;
You have access
Feulgen Staining Remains the Gold Standard for Precise DNA Image Cytometry
STEFAN BIESTERFELD, SASCHA BECKERS, MARIA DEL CARMEN VILLA CADENAS and MARTIN SCHRAMM

Anticancer Research January 2011, 31 (1) 53-58;
You have access
EGFR Codon 497 Polymorphism – Implications for Receptor Sensitivity to Inhibitors in HNSCC Cell Lines
VANESSA KROHN, SUSANNE WIEGAND, JOCHEN A. WERNER and ROBERT MANDIC

Anticancer Research January 2011, 31 (1) 59-65;
You have access
Overexpression of Interleukin-6 Suppresses Cisplatin-induced Cytotoxicity in Esophageal Squamous Cell Carcinoma Cells
KENTARO SUCHI, HITOSHI FUJIWARA, SHINICHI OKAMURA, HIROKO OKAMURA, SEIJI UMEHARA, MOMOKO TODO, AKINOBU FURUTANI, MASAYUKI YONEDA, ATSUSHI SHIOZAKI, TAKESHI KUBOTA, DAISUKE ICHIKAWA, KAZUMA OKAMOTO and EIGO OTSUJI

Anticancer Research January 2011, 31 (1) 67-75;
You have access
TIP60 as a Potential Marker for the Malignancy of Gastric Cancer
KAZUMA SAKURABA, KAZUAKI YOKOMIZO, ATSUSHI SHIRAHATA, TETSUHIRO GOTO, MITSUO SAITO, KAZUYOSHI ISHIBASHI, GAKU KIGAWA, HIROSHI NEMOTO and KENJI HIBI

Anticancer Research January 2011, 31 (1) 77-79;
You have access
Cytotoxicity of Thymus vulgaris Essential Oil Towards Human Oral Cavity Squamous Cell Carcinoma
SERKAN SERTEL, TOLGA EICHHORN, PETER K. PLINKERT and THOMAS EFFERTH

Anticancer Research January 2011, 31 (1) 81-87;
You have access
Thyroid Hormones (T3 and T4): Dual Effect on Human Cancer Cell Proliferation
GIULIA MORIGGI, CECILIA VERGA FALZACAPPA, CLAUDIA MANGIALARDO, SIMONA MICHIENZI, ANTONIO STIGLIANO, ERCOLE BRUNETTI, VINCENZO TOSCANO and SILVIA MISITI

Anticancer Research January 2011, 31 (1) 89-96;
You have access
Prognostic Value of Mitotic Counts in Breast Cancer of Saudi Arabian Patients
ABDELBASET BUHMEIDA, JAUDAH AL-MAGHRABI, ADNAN MERDAD, FATIMA AL-THUBAITY, ADEEL CHAUDHARY, MAMDOOH GARI, ADEL ABUZENADAH, YRJÖ COLLAN, KARI SYRJÄNEN and MOHAMMED AL-QAHTANI

Anticancer Research January 2011, 31 (1) 97-103;
You have access
NK4 Gene Therapy Combined with Cisplatin Inhibits Tumour Growth and Metastasis of Squamous Cell Carcinoma
GOICHI MATSUMOTO, YASUSHI OMI, USHAKU LEE, EIRO KUBOTA and YASUHIKO TABATA

Anticancer Research January 2011, 31 (1) 105-111;
You have access
Constitutively Active FGFR3 with Lys650Glu Mutation Enhances Bortezomib Sensitivity in Plasma Cell Malignancy
MASAYASU OTSUKA, MASAO MIZUKI, JIRO FUJITA, SUMIN KANG and YUZURU KANAKURA

Anticancer Research January 2011, 31 (1) 113-122;
You have access
The Tumor Suppressive Effect of Angiotensin II Type 1 Receptor Antagonist in a Murine Osteosarcoma Model
JUNJI WASA, HIDESHI SUGIURA, EIJI KOZAWA, KEISHI KOHYAMA, KENJI YAMADA and OSAMU TAGUCHI

Anticancer Research January 2011, 31 (1) 123-127;
You have access
New Sarcomatoid Cancer Cell Line SAR-HCV Established from a Hepatitis C Virus-related Liver Tumour Lesion
DAR-IN TAI, YA-JU SHEN, WEN-HUI WENG, HUI-WEN CHEN, CHEN-CHEN KANG, TSE-CHING CHEN and SHUEN-KUEI LIAO

Anticancer Research January 2011, 31 (1) 129-137;
You have access
Oncogramme, A New Promising Method for Individualized Breast Tumour Response Testing for Cancer Treatment
S. GIRAUD, E. LOUM, B. BESSETTE, V. FERMEAUX and C. LAUTRETTE

Anticancer Research January 2011, 31 (1) 139-145;
You have access
Hepatic Arterial Infusion in the Treatment of Liver Metastases with PEG Liposomes in Combination with Degradable Starch Microspheres (DSM) Increases Tumor 5-FU Concentration. An Animal Study in CC-531 Liver Tumor-bearing Rats
U. POHLEN, R. RESZKA, H.J. BUHR and G. BERGER

Anticancer Research January 2011, 31 (1) 147-152;
You have access
Improvement of Biodistribution with PEGylated Liposomes Containing Docetaxel with Degradable Starch Microspheres for Hepatic Arterial Infusion in the Treatment of Liver Metastases: A Study in CC-531 Liver Tumor-bearing WAG RIJ Rats
U. POHLEN, H.J. BUHR and G. BERGER

Anticancer Research January 2011, 31 (1) 153-159;
You have access
Neem Leaf Extract Induces Radiosensitization in Human Neuroblastoma Xenograft Through Modulation of Apoptotic Pathway
JAMUNARANI VEERARAGHAVAN, SHEEJA ARAVINDAN, MOHAN NATARAJAN, VIBHUDUTTA AWASTHI, TERENCE S HERMAN and NATARAJAN ARAVINDAN

Anticancer Research January 2011, 31 (1) 161-170;
You have access
MAGE Expressions Mediated by Demethylation of MAGE Promoters Induce Progression of Non-small Cell Lung Cancer
NAOKI YANAGAWA, GEN TAMURA, HIROYUKI OIZUMI, MAKOTO ENDOH and TEIICHI MOTOYAMA

Anticancer Research January 2011, 31 (1) 171-175;
You have access
Oleic Acid Is the Active Component in the Mushroom Daedalea gibbosa Inhibiting Bcr-Abl Kinase Autophosphorylation Activity
HAZEM KHAMAISIE, SHERBEL SUSSAN, MICHAEL TAL, YOUSEF NAJAJREH, MARTIN RUTHARDT and JAMAL MAHAJNA

Anticancer Research January 2011, 31 (1) 177-183;
You have access
Chemical Composition and Antiproliferative Activity of Essential Oil from the Leaves of a Medicinal Herb, Levisticum officinale, against UMSCC1 Head and Neck Squamous Carcinoma Cells
SERKAN SERTEL, TOLGA EICHHORN, PETER K. PLINKERT and THOMAS EFFERTH

Anticancer Research January 2011, 31 (1) 185-191;
You have access
Anticancer and Antimetastatic Activities of Renieramycin M, a Marine Tetrahydroisoquinoline Alkaloid, in Human Non-small Cell Lung Cancer Cells
HASSERI HALIM, PREEDAKORN CHUNHACHA, KHANIT SUWANBORIRUX and PITHI CHANVORACHOTE

Anticancer Research January 2011, 31 (1) 193-201;
You have access
ATM/ATR and SMAD3 Pathways Contribute to 3-Indole-induced G₁ Arrest in Cancer Cells and Xenograft Models
SIN-MING HUANG, KWOK-TUNG LU and YI-CHING WANG

Anticancer Research January 2011, 31 (1) 203-208;
You have access
Effect of Genistein on p90RSK Phosphorylation and Cell Proliferation in T47D Breast Cancer Cells
JOHN GWIN, NEIL DREWS, SYED ALI, JUSTIN STAMSCHROR, MATTHEW SORENSON and TALITHA T. RAJAH

Anticancer Research January 2011, 31 (1) 209-214;
You have access
Increased Efficacy and Reduced Cardiotoxicity of Metronomic Treatment with Cyclophosphamide in Rat Breast Cancer
VALENTINA K. TODOROVA, YIHONG KAUFMANN and V. SUZANNE KLIMBERG

Anticancer Research January 2011, 31 (1) 215-220;
You have access
Association of Cyclooxygenase 2 Polymorphic Genotypes with Prostate Cancer in Taiwan
HSI-CHIN WU, CHAO-HSIANG CHANG, HUNG-LUNG KE, WEN-SHIN CHANG, HUI-NI CHENG, HUI-HUI LIN, CHI-YU WU, CHIA-WEN TSAI, RU-YIN TSAI, WOEI-CHUNG LO and DA-TIAN BAU

Anticancer Research January 2011, 31 (1) 221-225;
You have access
Significant Association of Cyclin D1 Single Nucleotide Polymorphisms with Oral Cancer in Taiwan
MING-HSUI TSAI, CHIA-WEN TSAI, YUNG-AN TSOU, CHUN-HUNG HUA, CHIA-FANG HSU and DA-TIAN BAU

Anticancer Research January 2011, 31 (1) 227-231;
You have access
Ruta graveolens Extract Induces DNA Damage Pathways and Blocks Akt Activation to Inhibit Cancer Cell Proliferation and Survival
KHALDA FADLALLA, ANGELA WATSON, TESHOME YEHUALAESHET, TIMOTHY TURNER and TEMESGEN SAMUEL

Anticancer Research January 2011, 31 (1) 233-241;

Clinical Studies

You have access
Detection and Significance of Parametrial Micrometastases in Early-stage Cervical Cancer
PAULA C. BRADY, XIAOWEI CHEN, WILLIAM M. BURKE, ISRAEL DEUTSCH, XUMING SUN, THOMAS J. HERZOG and JASON D. WRIGHT

Anticancer Research January 2011, 31 (1) 243-247;
You have access
Phase II Study of Saracatinib (AZD0530) for Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC)
MATTHEW G. FURY, SHRUJAL BAXI, RONGLAI SHEN, KATHERINE W. KELLY, BRYNNA L. LIPSON, DIANE CARLSON, HILDA STAMBUK, SOFIA HAQUE and DAVID G. PFISTER

Anticancer Research January 2011, 31 (1) 249-253;
You have access
A Phase II Study of Capecitabine, Oxaliplatin, Bevacizumab and Cetuximab in the Treatment of Metastatic Colorectal Cancer
NAN SOON WONG, NISHAN H. FERNANDO, ANDREW B. NIXON, STEPHANIE CUSHMAN, MEBEA AKLILU, JOHANNA C. BENDELL, MICHAEL A. MORSE, GERARD C. BLOBE, JILL ASHTON, HERBERT PANG and HERBERT I. HURWITZ

Anticancer Research January 2011, 31 (1) 255-261;
You have access
Expression of LGR5, an Intestinal Stem Cell Marker, During Each Stage of Colorectal Tumorigenesis
KAYOKO TAKEDA, ICHIRO KINOSHITA, YASUSHI SHIMIZU, YOSHIHIRO MATSUNO, TOSHIAKI SHICHINOHE and HIROTOSHI DOSAKA-AKITA

Anticancer Research January 2011, 31 (1) 263-270;
You have access
The Role of Pelvic Lymph Node Dissection During Radical Cystectomy for Bladder Cancer
EUGENIO BRUNOCILLA, REMIGIO PERNETTI and GIUSEPPE MARTORANA

Anticancer Research January 2011, 31 (1) 271-275;
You have access
Two Cases with a Long-term Survival Following Multidisciplinary Treatment for Recurrent Breast Cancer After Surgery
HIDETAKA URAMOTO and TAKESHI HANAGIRI

Anticancer Research January 2011, 31 (1) 277-279;
You have access
C-erbB-3 Expression in Non-small Cell Lung Cancer (NSCLC) Patients Treated by Erlotinib
INGRID CsTOTH, GÉRALDINE ANTHOINE, THIERRY BERGHMANS, CÉLINE MASCAUX, MARIANNE PAESMANS, JEAN-PAUL SCULIER and ANNE-PASCALE MEERT

Anticancer Research January 2011, 31 (1) 281-285;
You have access
A Phase II Study of Weekly Paclitaxel and Doxifluridine Combination Chemotherapy for Advanced/Recurrent Gastric Cancer
IZUMI TAKEYOSHI, FUJIO MAKITA, YOSHIFUMI TANAHASHI, SHIGERU IWAZAKI, TETSUSHI OGAWA, NAOKI TOMIZAWA, SEIJI NAKAMURA, HITOSHI ISHIKAWA, TOSHIHIRO OHYA, SHINICHI KAKINUMA, KATSUNAO NAKAGAMI, YOSHIHIRO SATO, TETSUYA KOYANO, TAKASHI ROPPONGI, MASARU IZUMI, JUNYA KOBAYASHI, SUSUMU KAWATE, YUTAKA SUNOSE, MITSUNOBU KOBAYASHI, TATSUYA YAMADA and ICHIRO SAKAMOTO

Anticancer Research January 2011, 31 (1) 287-291;
You have access
Cortactin in Breast Cancer: Analysis with Tissue Microarray
SHYR-MING SHEEN-CHEN, CHUN-YING HUANG, YU-YIN LIU, CHAO-CHENG HUANG and REI-PING TANG

Anticancer Research January 2011, 31 (1) 293-297;
You have access
Successful S-1 Monotherapy for Chemorefractory Thymic Carcinoma
TOMONOBU KOIZUMI, TOSHIHIKO AGATSUMA, YOSHIMICHI KOMATSU and KEISHI KUBO

Anticancer Research January 2011, 31 (1) 299-301;
You have access
Prognostic Value of the Human Antigen R (HuR) in Human Breast Cancer: High Level Predicts a Favourable Prognosis
ZHU YUAN, ANDREW J. SANDERS, LIN YE, YU WANG and WEN G. JIANG

Anticancer Research January 2011, 31 (1) 303-310;
You have access
Pronounced Tumour Regression after Radiotherapy is Associated with Negative/Weak Glucose Transporter-1 Expression in Rectal Cancer
E. KORKEILA, P.M. JAAKKOLA, K. SYRJÄNEN, S. PYRHÖNEN and J. SUNDSTRÖM

Anticancer Research January 2011, 31 (1) 311-315;
You have access
Randomized Phase II Study of Paclitaxel and Carboplatin or Vinorelbine in Advanced Non-small Cell Lung Cancer
KRISTOPH JAHNKE, ULRICH KEILHOLZ, DIANA LÜFTNER, ECKHARD THIEL and ALEXANDER SCHMITTEL

Anticancer Research January 2011, 31 (1) 317-323;
You have access
Clinical Significance of STC1 Gene Expression in Patients with Colorectal Cancer
SHUZO TAMURA, TAKASHI OSHIMA, KAZUE YOSHIHARA, AMANE KANAZAWA, TAKANOBU YAMADA, DAISUKE INAGAKI, TSUTOMU SATO, NAOTO YAMAMOTO, MANABU SHIOZAWA, SOICHIRO MORINAGA, MAKOTO AKAIKE, CHIKARA KUNISAKI, KATSUAKI TANAKA, MUNETAKA MASUDA and TOSHIO IMADA

Anticancer Research January 2011, 31 (1) 325-329;
You have access
Temsirolimus in Metastatic Chromophobe Renal Cell Carcinoma after Interferon and Sorafenib Therapy
BERNARD PAULE and NATHALIE BRION

Anticancer Research January 2011, 31 (1) 331-333;
You have access
5-FU-induced Hyperammonemic Encephalopathy in a Case of Metastatic Rectal Adenocarcinoid Successfully Rechallenged with the Fluoropyrimidine Analog, Capecitabine
POOJA P. ADVANI and MARWAN G. FAKIH

Anticancer Research January 2011, 31 (1) 335-338;
You have access
Predictive Value of Serum Biomarkers in Patients After Portal Vein Embolization (PVE): A Pilot Study
VLADISLAV TRESKA, ONDREJ TOPOLCAN, JINDRA VRZALOVA, TOMAS SKALICKY, ALAN SUTNAR, VACLAV LISKA, JAKUB FICHTL, ANDREA NARSANSKA, JIRI FERDA, INKA TRESKOVA, HYNE MIRKA and BORIS KREUZBERG

Anticancer Research January 2011, 31 (1) 339-344;
You have access
The Dynamics of Serum Tumor Markers in Predicting Metastatic Uveal Melanoma (Part 1)
VIVIAN BARAK, IGOR KAISERMAN, SHAHAR FRENKEL, KEREN HENDLER, INNA KALICKMAN and JACOB PE'ER

Anticancer Research January 2011, 31 (1) 345-349;
You have access
Trends in Liver Function Tests: A Comparison with Serum Tumor Markers in Metastatic Uveal Melanoma (Part 2)
KAREN HENDLER, JACOB PE'ER, IGOR KAISERMAN, RONEN BARUCH, INNA KALICKMAN, VIVIAN BARAK and SHAHAR FRENKEL

Anticancer Research January 2011, 31 (1) 351-357;
You have access
Pharmacogenetic Tailoring of Irinotecan-based First-line Chemotherapy in Metastatic Colorectal Cancer: Results of a Pilot Study
GILLES FREYER, AUDE DURET, GERARD MILANO, ETIENNE CHATELUT, CHRISTINE REBISCHUNG, JEAN-PIERRE DELORD, YACINE MERROUCHE, GERARD LLEDO, MARIE-CHRISTINE ETIENNE and CLAIRE FALANDRY

Anticancer Research January 2011, 31 (1) 359-366;
You have access
Risk of Ipsilateral Breast Tumor Recurrence in Patients Treated with Tamoxifen or Anastrozole Following Breast-conserving Surgery with or without Radiotherapy
MAKOTO ISHITOBI, SAKI NAKAHARA, YOSHIFUMI KOMOIKE, KAZUYOSHI MOTOMURA, HIROKI KOYAMA and HIDEO INAJI

Anticancer Research January 2011, 31 (1) 367-371;
You have access
Parameters of Biological Activity in Colorectal Cancer
SARKA SVOBODOVA, ONDREJ TOPOLCAN, LUBOS HOLUBEC, MIROSLAV LEVY, LADISLAV PECEN and STEPAN SVACINA

Anticancer Research January 2011, 31 (1) 373-378;

Main menu

User menu

Search

Table of Contents

Experimental Studies

Clinical Studies

In this issue

Jump to